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Abstract: An on-plate specific enrichment method is
presented for the direct analysis of peptides phosphory-
lation. An array of sintered TiO2 nanoparticle spots was
prepared on a stainless steel plate to provide porous
substrate with a very large specific surface and durable
functions. These spots were used to selectively capture
phosphorylated peptides from peptide mixtures, and the
immobilized phosphopeptides could then be analyzed
directly by MALDI MS after washing away the nonphos-
phorylated peptides. -Casein and protein mixtures were
employed as model samples to investigate the selection
efficiency. In this strategy, the steps of phosphopeptide
capture, purification, and subsequent mass spectrometry
analysis are all successfully accomplished on a single
target plate, which greatly reduces sample loss and
simplifies analytical procedures. The low detection limit,
small sample size, and rapid selective entrapment show
that this on-plate strategy is promising for online enrich-
ment of phosphopeptides, which is essential for the
analysis of minute amount of samples in high-throughput
proteome research.
Keywords: phosphorylated peptides • enrichment • TiO2
nanoparticles • MALDI-TOF MS
Introduction
Mass spectrometry, including matrix-assisted laser desorp-
tion/ionization mass spectrometry (MALDI MS) and electro-
spray ionization mass spectrometry (ESI MS), has played an
important role in protein profiling research.1 MALDI is a
standard ionization technique to transfer neutral solid-state
samples to gas-phase ions for further analysis by mass spec-
trometry.2 Several alternative substrates and matrices have
been introduced over the recent years to add additional
functions on MALDI target plates. Plates covered with specific
solid-phases would present special affinities to target biomol-
ecules. For example, polymer-coated target plates have been
introduced to capture specific proteins from complex samples,
based on ion exchange or reverse-phase mechanisms, and then
the captured proteins could be further analyzed by mass
spectrometry.3–6
Phosphorylation is one of the most important post-transla-
tional modifications of proteins, and this reversible procedure
regulates a wide range of biological processes: transmitting
signals, labeling proteins for degradation, and controlling
cellular growth and metabolism.7–9 To understand these bio-
logical functions at a molecular level, a characterization of
phosphorylated proteins is required. Recently, MS-based tech-
niques were proven to be efficient tools for phosphorylation
sites mapping.9–12 However, the low abundance of phospho-
rylated peptides and the signal suppression of fruitful non-
phosphorylated peptides make the analysis still difficult. Fur-
thermore, compared with unmodified peptides, the positive
ions formation of phosphopeptides is much less efficient due
to the increased acidity, which largely hampers the identifica-
tion of phosphopeptides by MS.13 Therefore, separation and
enrichment of phosphorylated peptides from proteolytic digest
mixtures are crucial steps. To date, several strategies have been
developed to meet this requirement. One strategy based on the
specific affinity between antibodies and phosphorylated amino
acids has been established for enriching proteins phosphory-
lated on tyrosine.14,15 However, this technique is limited by the
high cost of antibodies. Another commonly used strategy is
immobilized metal ion affinity chromatography (IMAC),16–21
which remains a standard method for specifically enriching
phosphorylated peptides prior to MS nowadays, where Fe3+
or Ga3+ ions are commonly used. The IMAC approach is based
on ionic interactions; thus, nonspecific enrichment is unavoid-
able. It has been reported that peptides rich in glutamic,
aspartic, cysteine, and histidine residues are often copurified.8
Alternatively, metal oxides such as ZrO2,
9,10 TiO2,
7,11 and
Al2O3
8,22 have been used to selectively concentrate phospho-
peptides, where the phosphate functional groups can bind to
the surface of metal oxide particles. Because of their stability
over a wide pH range, acidic buffers can be employed to avoid
nonspecific binding. Recently, a comprehensive study shows
that this so-called metal oxide affinity chromatography tech-
nique could provide information that is complementary to
IMAC.23 On the basis of these strategies, a number of works
have been reported using on-column or in-solution tech-
niques.7,12 However, additional procedures must be employed
in these works, such as desalting usually necessary for on-
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column enrichment systems, centrifugation for in-solution
enrichment systems, and sample manipulation from the sepa-
ration to the detection devices for both systems. These proce-
dures inevitably introduce possible sample loss and impede
the integration of analytical procedures. To characterize phos-
phoproteins more efficiently, it is preferable to develop a simple
online approach where the enrichment procedure could meet
the requirement of high-throughput proteome analysis, espe-
cially when the sample available is limited.
Herein, a novel plate-based technique for fast enrichment
of phosphopeptides from substoichiometric mixtures is de-
scribed to address these issues. MALDI target plates are covered
with an array of sintered TiO2 nanoparticle spots. The spot is
first used as a solid phase extractor to adsorb interacting
molecules, and then as a stable support of the MALDI matrix
for the ionization of those retained molecules, which are further
analyzed by mass spectrometry. The TiO2 spot has a very large
specific to geometric area ratio, giving it a high-trapping
capacity for its target species. The phosphopeptides can then
be directly collected on the target plate efficiently without any
other additional procedures. As a result, this in situ enrichment
approach is very effective, sensitive, and especially suitable for
online analysis coupled with sample separation. The tryptic
digests of -casein and drinking milk were employed as model
samples to examine the feasibility of this highly specific on-
plate enrichment method. The TiO2 array-based affinity target
plate provides a very efficient tool to specifically analyze
phosphopeptides of a biological sample, for example, in the
study of post-translational modifications.
Experimental Section
Reagents. Phosphoric acid (g85%) and acetic acid (g99%)
were purchased from Shanghai Feida Chemical reagents Ltd.
Ammonium hydroxide solution (25∼28%) was obtained from
Shanghai No.4 Reagent Company, Kunshan. Titanium dioxide
nanoparticles were obtained from Degussa (P25, Germany).
Acetonitrile (ACN, 99.9%) and trifluoroacetic acid (TFA, 99.8%)
were purchased from Merck (Darmstadt, Germany), while
ammonium bicarbonate, 2,5-dihydroxybenzoic acid (DHB,
98%), -casein (from bovine milk, 90%), bovine serum albumin
(BSA, 95%), myoglobin (from horse heart, 95%), trypsin (from
bovine pancreas), and PHOS-Select iron affinity gel were
obtained from Sigma (St. Louis, MO). All these reagents were
used as received without further purification. Drinking milk was
purchased from a local grocery store. Deionized water (18.4
MΩ · cm) used for all experiments was obtained from a Milli-Q
system (Millipore, Bedford, MA).
Preparation of a Stable Suspension of Commercial TiO2
Nanoparticles. The P25 TiO2 particles were heated at 300 °C
for 2 h and then separated in a mortar for 2–3 h. During the
separation procedure, 1 mL of 10% acetic acid (in water) was
added for every 1 g of TiO2 particles drop by drop to keep them
wet. After being separated, the nanoparticles were suspended
in an aqueous solution of ethanol (89% (v/v), TiO2 concentra-
tion was 100 mg/mL), followed by sonication for 1 h. The
resulting TiO2 suspension could keep stable for several months.
Before use, this suspension was diluted in water by 25×. Of
course, one cannot assume the absence of nanoparticle ag-
gregation in the suspension, but the present protocol provides
enough dispersion to obtain a homogeneous suspension that
can be easily manipulated.
Preparation of TiO2-Modified Target Plate. The diluted
suspension of TiO2 nanoparticles was dropped as an array of
spots (∼2 µL for each spot) on a stainless steel plate and dried
at room atmosphere and temperature. The resulting modified
target plate was subsequently heated in an oven at 400 °C for
1 h (the oven temperature was ramped from room temperature
to 400 °C in 30 min) and naturally cooled-down and stored in
a desiccator.
Tryptic Digestion of BSA, Myoglobin, -Casein, and
Drinking Milk. One milligram of BSA, myoglobin, or -casein
was dissolved in 1 mL of ammonium bicarbonate aqueous
solution (25 mM, pH ∼8) separately, denatured at 100 °C for 5
min, and digested with trypsin for 12 h at 37 °C (enzyme-to-
protein ratio of 1:30 (w/w)). Thirty microliters of drinking milk
was diluted in 900 µL of NH4HCO3 aqueous solution at 25 mM.
This solution was then centrifugated at 16 000 rpm for 15 min,
and the supernatant was saved for tryptic digestion. After
denaturation at 100 °C for 5 min, the supernatant was incu-
bated for 12 h at 37 °C with 30 µg of trypsin for proteolysis.
This tryptic digest product from milk was diluted by 25× in a
DHB buffer (DHB at 20 mg/mL in ACN/water/TFA, 50/49.9/
0.1% (v/v)) or deionized water before analysis.
On-Plate Extraction of Phosphopeptides. The digest prod-
ucts of BSA, -casein, and drinking milk were diluted in given
volumes of 2,5-DHB buffer (DHB at 20 mg/mL in ACN/water/
TFA, 50/49.9/0.1% (v/v)) to adjust the hydrolysates to lower
pH and required concentrations. Then, the digests were ad-
sorbed on the TiO2-modified target plate for either 30 or 5 min
and washed with a solution of 2,5-DHB (DHB at 20 mg/mL in
ACN/water/TFA, 50/49.9/0.1% (v/v)). Finally, 0.5 µL of 400 mM
ammoniac aqueous solution was added to desorb the phos-
phorylated peptides bound to the TiO2. A total of 0.3µL of TFA
solution (2% in water (v/v)) was added on the sample spot and
dried at room atmosphere before the deposition of 0.5µL of
DHB matrix (20 mg/mL in ACN/water/H3PO4, 50/49/1% (v/
v)) overlayer. The phosphorylated peptides captured on the
TiO2-modified target plate were analyzed by MALDI-TOF MS.
The reproducibility was examined by repeating each experi-
ment at least three times. For comparison, the digests of BSA,
-casein, and drinking milk diluted in deionized water at
different concentrations were analyzed on a blank plate using
a DHB matrix. A volume of 0.5µL of each sample was dropped
on the plate and dried at ambient atmosphere followed by the
deposition of 0.5 µL of DHB matrix.
Immobilized Metal-Affinity Chromatography (IMAC). IMAC
purification of phosphorylated peptides was performed ac-
cording to previous reports7,24 with minor changes. Briefly,
samples were diluted in a washing/loading buffer of 250 mM
acetic acid/30% ACN, and 100 µL of each sample was added
to 20 µL of IMAC beads (PHOS-Select iron affinity gel; Sigma),
previously washed three times using the washing/loading
buffer. After incubation at room temperature with vigorous
shaking for 30 min, the supernatant was removed, and the resin
was washed three times with 100 µL of washing/loading buffer
to remove nonspecifically adsorbed peptides. The bound
peptides were then eluted using 20 µL of 400 mM NH4OH into
a tube, and 0.5 µL of the solution was dropped on a blank target
plate. After drying at ambient atmosphere, 0.3 µL of 2% TFA
and 0.5 µL of DHB matrix were subsequently added before
MALDI-TOF MS analysis.
MALDI-TOF MS and Data Analysis. All the MALDI-TOF
mass spectrometry experiments were performed on an Applied
Biosystems 4700 proteomics analyzer (Applied Biosystems)
equipped with a Nd:YAG laser operating at 355 nm, a repetition
rate of 200 Hz, an acceleration voltage of 20 kV, and a delayed
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ion-extraction device. All mass spectra were obtained in the
positive ion reflector mode with an accumulation of 2000 laser
shots and calibrated using an external calibration equation
generated from the ion signal of tryptic digest of myoglobin.
The laser intensity was adjusted to obtain good resolution and
signal-to-noise ratio (S/N) generally from 6000 to 7000 instru-
ment units varied with different samples. In all experiments,
DHB (20 mg/mL) in 49% ACN and 1% phosphoric acid was
used as the matrix to help ionization. Mass spectrometric data
analysis was performed with Data Explorer (TM) Software and
the FindMod tool available on the ExPASy (Expert Protein
Analysis System) proteomics server of the Swiss Institute of
Bioinformatics (SIB) (http://expasy.org/). The masses and
intensities of special peaks were read out using the Data
Explorer (TM) Software, and then sent to the FindMod tool for
database searching, where the experimentally measured pep-
tide masses were compared with the theoretical peptides
calculated from a specified Swiss-Prot/TrEMBL entry to finish
the peak identification.
Results and Discussion
On-Plate Enrichement of Phosphorylated Peptides
Based on a TiO2 Nanoparticle Modified Target Plate. Drops
of a suspension of nanoparticles are applied on a plain stainless
steel plate to form an array of spots (Figure 1a). After solvent
evaporation, the particles are heated at 400 °C for sintering,
which is an important procedure to ensure the highest sorbing
capacity and form a stable frit support phase for samples and
matrix. When the TiO2 frit spots are exposed to the samples,
the phosphorylated peptides are selectively captured on the
modified target plate. Afterward, a washing step is employed
to effectively remove the nonspecifically bound peptides. A
solution of 2,5-DHB (DHB at 20 mg/mL in ACN/water/TFA,
50/49.9/0.1% (v/v)) is used as elution solution, which has been
proven capable of specifically displacing nonspecifically bound
acidic peptides from the TiO2.
7 This solution is also used to
dilute the digest products of proteins to avoid adsorption of
nonphosphorylated peptides. Following the washing step, an
aqueous ammoniac solution is added to desorb the captured
phosphorylated peptides from the TiO2 substrate. After the
addition of an organic acid overlayer, part of the matrix is
ablated and released in gas phase with samples under the
irradiation of UV laser (Figure 1b), and then the released ions
are driven by electric fields to a mass spectrometer for
measurements.
This on-target enrichment strategy was first studied by
extracting phosphorylated peptides from the -casein digest
with varied concentrations in 30 min. -Casein is a major
protein component of milk, containing 5 different phospho-
rylated sites on serine, and has been widely used as a model
sample in the study of phosphoproteome analysis.7,9–12,25 With
the well-studied sequence, the theoretical masses of the tryptic
digest peptides derived from -casein could be calculated, and
the detected peaks on mass spectra could be identified by
comparison with theoretical results. Figure 2a shows the mass
spectrum of the tryptic digest of -casein at a concentration
of 8.5 × 10-7 M (90% of purity) obtained on the TiO2-modified
plate. Almost all the peaks observed are related to phospho-
rylated peptides. The peaks 12, 14, and 19 (m/z 2061.8, 2556.1,
and 3122.3) are derived from phosphopeptides of -casein,
while the peaks marked 3, 4, 6, 7, 9, and 10 (m/z 1466.6, 1539.7,
1594.7, 1660.8, 1927.7, and 1952.0) are derived from phospho-
peptides of R-casein. Here, not only all the five phosphorylated
sites of -casein are identified from three phosphopeptides, but
also six phosphorylated peptides of R-casein are clearly ob-
served due to the substoichiometric impurity present in
-casein (about 10% or less in the sample). The detailed
sequence information is listed in Table 1. This result indicates
that the plate-based in situ phosphopeptides enrichment
method is really feasible. The peaks 1, 2, and 5 (m/z 1031.4,
1278.6, and 1561.7) could not be directly identified during the
database searching. However, we observe that each isotope
peak of them is separated by 0.5 m/z units, respectively (Figure
2a, inset), indicating a characteristic of doubly charged ions.
By calculation, we suspect that they could be attributed to the
doubly charged ions of the three phosphopeptides 12, 14, and
19. Though it is unusual to see doubly charged ions with such
a small molecular weight in MALDI mass spectrum, a similar
phenomenon has been reported previously.11 We can also
observe the metastable loss of H3PO4 from parent ions during
the fly procedure in TOF-tube, which further supports the
identification of phosphorylation in proteins. The peaks marked
11 and 13 (m/z 1968.3 and 2462.6) are assigned to the
dephosphorylated fragments of peptide 12 and 14, respectively,
and the peaks 16, 17, and 18 (m/z 2841.8, 2935.3, 3028.8) are
related to the dephosphorylated fragments of peptide 19, a
multiply phosphorylated peptide. Because of the reduced
kinetic energy, the mass difference between the metastable
peaks and their respective parent ions is ∼93.5 Da instead of
98 Da as expected for in-source fragments.26
Figure 1. (a) Picture of a self-made sintered TiO2-modified target plate with 81 spots. (b) Component drawing of the TiO2 array-based
MALDI plate. (1, steel plate; 2, sintered TiO2 layer; 3, UV laser; 4, releasedmatrix and sample). (c) Schematic illustration of the coordination
interaction between phosphophate groups and TiO2 nanoparticles.
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As a comparison, the same -casein digest (8.5 × 10-7 M,
90%) analyzed by MALDI-MS without pre-enrichment is shown
in Figure 2b. Only three weak peaks of phosphorylated pepti-
de–ions are detected (marked with 12, 14, and 19), in the
presence of numerous nonphosphopeptide signals. Therefore,
it is clear that phosphorylated peptides could be selectively
trapped by the TiO2 phase on the modified target plate.
Furthermore, when the concentration of sample is as low as
8.5 × 10-9 M, several phosphopeptide-related peaks (1, 11, 12,
14, and 19) are observed in the mass spectrum after on-plate
enrichment by the sintered TiO2 nanoparticles (Figure 2c). This
result shows that the on-target enrichment technique is sensi-
tive to phosphopeptide samples at low concentrations. When
the concentration is lowered down to 1.7 × 10-9 M, the peak
of phosphopeptide (12 at m/z 2061.8) can still be observed in
the mass spectrum (Figure 2d).
Highly Specific Enrichment of Phosphorylated Peptides
from Complex Peptide Mixtures. The selectivity of this on-
plate enrichment method was further evaluated by capturing
phosphorylated peptides from complex mixtures of tryptic
digests of BSA and -casein with ratios of 1:1, 15:1, and 100:1
(mol/mol) in 30 min. The concentration of BSA was fixed at
2.6 × 10-6 M in the mixtures. Figure 3a presents the mass
spectrum of the mixed tryptic digest of BSA and -casein at
ratio of 1:1 without pre-enrichment. Only two phosphopepti-
de–ion signals (12 and 19) are observed in the mass spectrum
at m/z 2061.8 and 3122.3, the other abundant ion signals
pertaining to nonphosphopeptides. In contrast, after enrich-
Figure 2. Mass spectra obtained using the TiO2-modified target plate to selectively enrich phosphorylated peptides from the tryptic
digests of -casein in 30 min at concentrations of 8.5 × 10-7 M (a), 8.5 × 10-9 M (c), and 1.7 × 10-9 M (d), respectively. Mass spectrum
of the tryptic digests of -casein (8.5 × 10-7 M) obtained on a regular plate without pre-enrichment (b).
Table 1. Detailed Information of the Observed Phosphorylated Peptides Obtained from Tryptic Digestion of R-Casein S1 and S2,
and -Caseina
peak
number observed m/z
number of
phosphate groups aa
amino acid
sequence
No. 3 1466.6 1 R-S2 (153–164) TVDMESTEVFTK
No. 4 1539.7 2 R-S2 (126–137) EQLSTSEENSKK
No. 6 1594.7 1 R-S2 (153–165) TVDMESTEVFTKK
No. 7 1660.8 1 R-S1 (106–119) VPQLEIVPNSAEER
No. 8 1832.8 1 (R-S1)b YLGEYLIVPNSAEER
No. 9 1927.7 2 R-S1 (43–58) DIGSESTEDQAMEDIK
No. 10 1952.0 1 R-S1 (104–119) YKVPQLEIVPNSAEER
No. 12 2061.8 1  (33–48) FQSEEQQQTEDELQDK
No. 14 2556.1 1  (33–52) FQSEEQQQTEDELQDKIHPF
No. 19 3122.3 4  (1–25) RELEELNVPGEIVESLSSSEESITR
a The phosphorylation sites are underlined. b A new sequence variant of the R-S1 casein in the region 104–119.7
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ment by the TiO2-modified target plate, the signals related to
phosphopeptides are highly enhanced and dominate the mass
spectrum as shown in Figure 3b. Three phosphorylated pep-
tides (12, 14, and 19) of -casein and five phosphopeptides (3,
6, 7, 9, and 10) of R-casein are clearly detected. The other peaks
are assigned to doubly charged ions (1, 2, and 5) and dephos-
phorylated fragment ions (11, 17, and 18). Panels c and d of
Figure 3 display the mass spectra obtained after the on-plate
enrichment of phosphopeptides from the tryptic digest mix-
tures of BSA and -casein at ratios of 15:1 and 100:1, respec-
tively. Three peaks (12, 14, and 19) of phosphopeptides at m/z
2061.8, 2556.1, and 3122.3 are selectively detected in the
presence of numerous abundant nonphosphopeptides from
BSA.
For comparison, a commercial IMAC product (PHOS-Select
iron affinity gel) was employed to enrich phosphopeptides from
the same digest mixtures of BSA and -casein with ratios of
1:1, 3:1, and 15:1 (mol/mol), where the concentration of BSA
was fixed at 2.6 × 10-6 M. IMAC is one of the most popular
techniques used for the isolation of phosphopeptides, which
has been utilized either in batchwise or in column formats to
develop semiautomatic or online analysis of phosphopro-
teome.24,27 The resulting mass spectra are presented in Figure
4. Three phosphorylated peptides (12, 14, and 19) derived from
-casein are clearly identified from the digest mixture of BSA
and -casein at a ratio of 1:1 (Figure 4a). The peaks of
phosphopeptides dominate the mass spectrum, and the phe-
nomenon of metastable loss of H3PO4 is well-observed. How-
ever, the selectivity is limited when excessive nonphospho-
peptides are included in the samples. Only two peaks related
to phosphopeptides (12 and 19) appear in the mass spectrum
with abundant nonphosphopeptide signals when the ratio of
BSA to -casein is at 3:1 (Figure 4b). As the ratio is further
increased to 15:1, almost no signals from phosphopeptides
could be detected (Figure 4c). Compared with the correspond-
ing results in Figure 3, one can see that the TiO2-modified plate
shows a better selective affinity to phosphorylated peptides.
Considering the less specific interaction between Fe3+ and
phosphopeptides,7,9 strategies have been developed as im-
provements over commercially available techniques recently.28
To further test the advantages of this on-plate enrichment
strategy, a complex sample from the tryptic digest of com-
mercial bovine milk, which contains fruitful phosphorylated
proteins such as R- and -casein, was employed. The milk
producer indicates a protein concentration of at least 3%, and
it has been reported that the casein content is about 66% (w/
w) in milk proteins,10 so that the concentration of casein used
in this experiment is approximately 10-6 M. Figure 5a shows
the mass spectrum of the tryptic digest of drinking milk without
pre-enrichment. Only one weak ion signal of phosphopeptide
at m/z 2061.8 appears together with abundant nonphospho-
peptide signals. After the on-plate enrichment of 30 min by
the sintered TiO2 nanoparticles, all the dominating peaks are
related to phosphorylated peptides (Figure 5b), including
peptides 12, 14, and 19 from -casein and 4, 7, 8, 9, and 10
from R-casein (Table 1).
Rapid in Situ Enrichment of Phosphorylated Peptides. To
speed-up the analysis and avoid sample loss, it is important
to develop an online method to concentrate phosphopeptides
following the separation steps prior to MALDI MS to provide
Figure 3. (a) Mass spectrum of the mixed tryptic digests of BSA and -casein with the ratio of 1:1 obtained on a regular target plate
without pre-enrichment. Mass spectra obtained using the TiO2 nanoparticle modified plate to selectively concentrate phosphorylated
peptides from the digest mixtures of BSA and -casein with ratios (mol/mol) of 1:1 (b) 15:1 (c), and 100:1 (d), respectively.
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high-throughput protein profiling especially when only a
limited amount of sample is available. Here, the TiO2 microar-
ray-based on-plate enrichment method is a promising strategy
to achieve this goal. Accordingly, 2 µL of tryptic digest of
-casein at different concentrations was deposited onto the
TiO2 spot on the modified target plate, subsequently incubated
at room temperature for only 5 min. After the washing step,
the captured phosphorylated peptides were directly analyzed
by MALDI-MS. The resulting mass spectra are shown in Figure
6. When the amount of tryptic digest on one TiO2 spot is 1.5
pmol, the obtained spectrum (Figure 6a) is quite good as
11 peaks related to phosphopeptides, including 3 peaks of
phosphopeptides (12, 14, 19) from -casein, 2 peaks of phos-
phopeptides (3, 10) from R-casein, and all the 6 dephospho-
rylated peaks (11, 13, 15 (m/z 2748.3), 16, 17, and 18) of parent
ions 12, 14, and 19 are clearly visible. The detection limit of
this on-plate strategy is about 30 fmol (Figure 6b), which is
comparable with the recently reported methods based on
chromatography,7,8,29 microchip,30 on-plate solid extraction,13
chemical modification,31 or magnetic beads.10–12,22 These
strategies generally exhibit high selectivity and sensitivity at
femtomole level (about 10–50 fmol)10,11,22 with a possible
combination with ESI or MALDI MS measurement,27,29 whereas
the present on-plate approach is a rapid in situ enrichment
technique for direct MALDI MS analysis. By integrating the
steps of phosphopeptide capture, purification, and subsequent
mass spectrometry analysis all on a single plate, the analytical
procedures are simplified and the possible sample loss is
reduced. In this way, the separation fractions from LC could
be directly deposited onto the TiO2 spots for phosphopeptide
enrichment prior to MALDI MS analysis.
The low detection limit and high selectivity of this on-plate
enrichment toward phosphopeptides could be attributed to an
intense coordination reaction occurring between TiO2 nano-
particles and phosphate groups.7 The dilution/elution buffer
also plays an important role, which includes a strong acid to
prevent ionic interaction, an organic solvent at high concentra-
tion to avoid hydrophobic interaction, and DHB to prevent
nonphosphopeptides adsorption. It has been proven that DHB
could enhance the selective enrichment of phosphopeptides
on TiO2 by competing with nonphosphorylated peptides for
the active binding sites.7 Moreover, the very large specific to
geometric area ratio of the TiO2 frit nanoparticle phase on the
target plate is another important factor to enhance the phos-
Figure 4. Mass spectra obtained using the IMAC beads to
selectively enrich phosphopeptides from the tryptic digest mix-
tures of BSA and -casein with ratio of (a) 1:1, (b) 3:1 and (c)
15:1 (mol/mol).
Figure 5. (a) Mass spectrum of the tryptic digests of commercial
bovine milk obtained on a regular target plate without pre-
enrichment. (b) Mass spectrum obtained using the TiO2 nano-
particle modified plate to selectively concentrate phosphorylated
peptides from the tryptic digest of the bovine milk in 30 min.
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phopeptide concentration efficiency. Indeed, for a sintered
nanoparticle layer of thickness h, the ratio of specific surface
area/geometric surface area is 3h/r for a hard sphere model
where r is the radius of the nanoparticles. For example, for a
layer thickness of 1 µm and a nanoparticle radius of 10 nm,
the specific surface area is 300× larger than the geometric area.
Experimentally, the effective area enhancement is smaller than
predicted as the relatively large peptides may not be able to
penetrate all the way through the nanoscale structure of the
TiO2 film. Nevertheless, the present TiO2-based spot provides
an enhanced adsorption capacity toward the target molecules.
Conclusions
In this paper, a novel on-plate specific enrichment approach
based on the interaction between phosphopeptides and TiO2
nanoparticles is proposed. A target plate modified with the
sintered TiO2 nanoparticles array has been prepared to specif-
ically concentrate phosphopeptides from complex peptide
mixtures without any additional procedures such as on-column
separation, desalting, or centrifugation. The captured phos-
phopeptides on the plate could be directly analyzed by MALDI
MS after the addition of an organic acid overlayer. We have
demonstrated that the TiO2 array-based target plate exhibits
high sensitivity and selectivity to phosphopeptides, while
significantly simplifying the analytical procedures and reducing
possible sample loss. With these advantages, the on-plate
strategy could be very useful for high-throughput analysis of
phosphopeptides and phosphoproteins coupled with LC or 2D
gel separation. Full automation of the system for real-world
proteome analysis is planned as the next step. It should provide
a very efficient tool for the large-scale study of post-transla-
tional modifications of proteins.
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